1-3 of 3
Arndt Vogel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial

Gontran Verset, Ivan Borbath, Mark Karwal, Chris Verslype, Hans Van Vlierberghe, Adel Kardosh, Vittorina Zagonel, Per Stal, Debashis Sarker, Daniel H. Palmer, Arndt Vogel, Julien Edeline, Stephane Cattan, Masatoshi Kudo, Ann-Lii Cheng, Sadahisa Ogasawara, Bruno Daniele, Stephen L. Chan, Jennifer J. Knox, Shukui Qin, Abby B. Siegel, Michael Chisamore, Ken Hatogai, Anran Wang, Richard S. Finn, Andrew X. Zhu
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF8.
DOI: https://doi.org/10.1158/1078-0432.CCR-21-3807
Published: 29 April 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study

Richard S. Finn, Masatoshi Kudo, Ann-Lii Cheng, Lucjan Wyrwicz, Roger K.C. Ngan, Jean-Frederic Blanc, Ari D. Baron, Arndt Vogel, Masafumi Ikeda, Fabio Piscaglia, Kwang-Hyub Han, Shukui Qin, Yukinori Minoshima, Michio Kanekiyo, Min Ren, Ryo Dairiki, Toshiyuki Tamai, Corina E. Dutcus, Hiroki Ikezawa, Yasuhiro Funahashi, Thomas R. Jeffry Evans
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (17): 4848–4858.
DOI: https://doi.org/10.1158/1078-0432.CCR-20-4219
Published: 01 September 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Biomarker Analyses of Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib with or without Erlotinib in the SEARCH Trial

Andrew X. Zhu, Yoon-Koo Kang, Olivier Rosmorduc, T.R. Jeffry Evans, Armando Santoro, Paul Ross, Edward Gane, Arndt Vogel, Michael Jeffers, Gerold Meinhardt, Carol E.A. Peña
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (19): 4870–4879.
DOI: https://doi.org/10.1158/1078-0432.CCR-15-2883
Published: 02 October 2016
View article
PDF
Includes: Supplementary data